BofA/Merrill Lynch analyst Colin Bristow reiterated a Buy rating and boosted his price target on Merck (NYSE: MRK) to $65.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE